Initiatives for Lymphatic Filariasis

Activity List

Current Distribution Status of DEC Tablets for Endemic Countries

2.05 billion tablets for 29 countries

as of October 2022

  • In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
  • In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
  • In October 2013, DEC tablet provision commenced from our Vizag plant
  • In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved

Countries where DEC tablets are supplied and countries where lymphatic filariasis (LF) is eliminated

●  Countries where distribution has commenced

Countries where LF is eliminated

LF elimination was achieved in Egypt, Kiribati, Thailand and Sri Lanka out of 29 countries, where Eisai has provided DEC tablets.


Previous Articles

Our Activities

An Overview of the Distribution Status of Lymphatic Filariasis Treatment to Endemic Countries and Disease Elimination Activities

An Overview of Business Activities for Improving Access to Medicines in Emerging and Developing Countries

An Overview of R & D Activities Related to the Three Major Infectious Diseases and Neglected Tropical Diseases

Related Links